insights_auto
Why is INO down ၂.၁၀%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၄၀ US$
arrow_downward
-၂.၁၀%(-၀.၀၃၀) 1D
၁.၃၉ US$
arrow_downward
-၀.၇၁% (-၀.၀၁၀၀)bedtimeAfter hours
Closed: နို ၁၆, GMT-၅ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၄၂ US$
High
၁.၄၈ US$
Low
၁.၃၇ US$
Mkt. cap
၂၆.၂၂ ကုဋေ
Avg. vol.
၁.၉၃ ကုဋေ
Volume
၀.၀၀
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
Open
၁.၄၂ US$
High
၁.၄၈ US$
Low
၁.၃၇ US$
Mkt. cap
၂၆.၂၂ ကုဋေ
Avg. vol.
၁.၉၃ ကုဋေ
Volume
၀.၀၀
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
TradingView
·
ပြီးခဲ့သည့် ၂ နာရီ
Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Much-Anticipated Nvidia Earnings, Anthropic IPO: SLS, BABA, JPM, OMER In Focus
ChartMill
·
ပြီးခဲ့သည့် ၁၀ နာရီ
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Motley Fool
·
ပြီးခဲ့သည့် ၁၄ နာရီ
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
Traders Union
·
ပြီးခဲ့သည့် ၇ နာရီ
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc